20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11458 | GPR40/FFAR1 modulator 1 | GPR | |
GPR40/FFAR1 modulator 1 is a Gq-coupled free fatty acid receptor 1 (GPR40/FFAR1) agonist and allosteric modulator. | |||
T15267 | GPR40 agonist 4 | Others | |
GPR40 agonist 4 is a potent free fatty acid agonist of receptor 1 (pEC50: 7.54). | |||
T11457 | GPR40 Activator 2 | Others | |
GPR40 Activator 2 is a highly effective activator of the GPR40 receptor. | |||
T11456 | GPR40 Activator 1 | Others | |
GPR40 Activator 1 is a potent GPR40 activator for treatment of type 2 diabetes. | |||
T11459 | GPR40 agonist 1 | Others | |
GPR40 agonist 1 is an effective new GPR40 agonist (EC50s: 17 nM and 2 nM for rGPR40 and hGPR40). | |||
T10507 | GPR40 Agonist 2 | GPR | |
GPR40 Agonist 2 is a GPR40 agonist. It can be used in the research of diabetes. | |||
T61055 | GPR40 agonist 6 | ||
GPR40 agonist 6 (Compound 7a) is a potent and selective agonist of free fatty acid receptor 1 ( FFAR1 or GPR40 ) with an EC 50 of 0.058 μM against GPR40 [1]. | |||
T62542 | GPR40 agonist 5 | ||
GPR40 agonist 5 is an orally active GPR40 (G protein-coupled receptor 40) agonist (EC50: 47 nM). gPR40 agonist 5 reduces blood glucose levels and improves glucose tolerance. gPR40 agonist 5 shows adequate control of hype... | |||
TQ0020 | AMG 837 calcium hydrate | GPR | |
AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM. AMG 837 calcium hydrate also shows highly selective over GPR41, GPR43, and GPR120 (EC50 > 10,000 nM). | |||
T1781 | GW9508 | GW 9508 | GPR , Potassium Channel |
GW9508(GW 9508) is a potent and selective agonist for FFA1 (GPR40), stimulates insulin secretion in a glucose-sensitive manner. | |||
T1286 | Vincamine | Angiopac,Oxybral,Devincan,Novicet,Equipur,Perval | GPR , Others |
Vincamine (Perval) is a major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders. | |||
T15810 | LY2922470 | GPR | |
LY2922470 reduces glucose levels along with significant enhancements in insulin and GLP-1, which is the potential for the treatment of type 2 diabetes mellitus (T2DM). LY2922470 is an effective, selective, and orally ava... | |||
T2351 | Fasiglifam | TAK875 | GPR |
Fasiglifam (TAK875) is a potent, selective and orally bioavailable GPR40 agonist. | |||
T60184 | TUG-499 | GPR , PPAR | |
TUG-499 is a selective free fatty acid receptor 1 (FFAR1 or GPR40) agonist (EC50: 7.39).TUG-499 has an affinity for FFAR1 or GPR40 over the related receptors FFA2, FFA3 and the nuclear receptor PPARγ, as well as other di... | |||
T7127 | DC260126 | Apoptosis , GPR | |
DC260126 is a small-molecule antagonist of FFA1 (GPR40) | |||
T22967 | MEDICA16 | MEDICA 16 | GPR , Others , ATP Citrate Lyase |
MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120. MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular TG content in gastrocnemius muscle with an increase in insu... | |||
T12883 | Fezagepras | PBI-4050,Setogepram | GPR |
Fezagepras (Setogepram) is an orally active GPR40 agonist and is an antagonist or inverse agonist of GPR84 with anti-inflammatory, anti-fibrotic, and anti-proliferative actions. | |||
T12375 | Fezagepras sodium | Setogepram sodium salt,PBI-4050 sodium salt | GPR |
Fezagepras sodium (Setogepram sodium salt) is an orally active GPR40 agonist and is an antagonist or inverse agonist for GPR84, with anti-fibrotic, anti-inflammatory and anti-proliferative actions. | |||
T17177 | TUG-424 | TUG424 | Others |
TUG-424 significantly enhances glucose-stimulated insulin secretion at 100 nM. TUG-424 is a potent and selective free fatty acid receptor 1 agonist (EC50: 32 nM). | |||
T14202 | AM-4668 | GPR | |
AM-4668 is a type 2 diabetes GPR40 agonist. For GPR40, in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), the EC50s are 3.6 nM and 36 nM, respectively. |